• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Senseonics Holdings, Inc.

    < Previous 1 2 Next >
    Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Participate in Upcoming Conferences
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Eversense® CGM System Receives iCGM Designation by the US FDA
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Announces Business Updates
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Announces Equity Grants To Employees Under Inducement Plan
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    Senseonics to Participate in the Jefferies Healthcare Conference
    From Senseonics Holdings, Inc.
    Via Business Wire
    Tickers SENS
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.